BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28552255)

  • 1. Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.
    Eggink FA; Mom CH; Boll D; Ezendam NPM; Kruitwagen RFPM; Pijnenborg JMA; van der Aa MA; Nijman HW
    Gynecol Oncol; 2017 Aug; 146(2):380-385. PubMed ID: 28552255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.
    Shigeta S; Nagase S; Mikami M; Ikeda M; Shida M; Sakaguchi I; Ushioda N; Takahashi F; Yamagami W; Yaegashi N; Udagawa Y; Katabuchi H
    J Gynecol Oncol; 2017 Nov; 28(6):e76. PubMed ID: 29027394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
    Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
    Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of early-stage endometrial cancer recurrence-A national cohort study.
    Jeppesen MM; Jensen PT; Gilså Hansen D; Iachina M; Mogensen O
    Eur J Cancer; 2016 Dec; 69():51-60. PubMed ID: 27816832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
    Xu MJ; Chu C; Rubin S; Lin LL
    Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.
    Soisson S; Ganz PA; Gaffney D; Rowe K; Snyder J; Wan Y; Deshmukh V; Newman M; Fraser A; Smith K; Herget K; Hanson HA; Wu YP; Stanford J; Werner TL; Setiawan VW; Hashibe M
    Gynecol Oncol; 2018 Mar; 148(3):499-506. PubMed ID: 29289418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
    Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
    Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
    van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
    Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of recurrence in patients with endometrial cancer: A retrospective study.
    Vizza E; Cutillo G; Bruno V; Sperduti I; Mancini E; Baiocco E; Chiofalo B; Cicchillitti L; Certelli C; Zampa A; Piccione E; Corrado G
    Eur J Surg Oncol; 2020 Sep; 46(9):1697-1702. PubMed ID: 32204935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
    Xiang M; English DP; Kidd EA
    Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
    Xiang M; English DP; Kidd EA
    Gynecol Oncol; 2019 Mar; 152(3):599-604. PubMed ID: 30551884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
    Kuku S; Williams M; McCormack M
    Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving oncologic outcomes for women with endometrial cancer: realigning our sights.
    Dowdy SC
    Gynecol Oncol; 2014 May; 133(2):370-4. PubMed ID: 24561031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.
    Loizzi V; Cormio G; Lorusso M; Latorre D; Falagario M; Demitri P; Scardigno D; Selvaggi LE
    Eur J Cancer Care (Engl); 2014 May; 23(3):380-4. PubMed ID: 24112088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
    Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S
    Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
    Gemer O; Segev Y; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Ben Arie A; Amit A; Levy T; Namazov A; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Lavie O
    Am J Obstet Gynecol; 2018 Aug; 219(2):181.e1-181.e6. PubMed ID: 29792852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
    Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
    Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
    Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
    Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of surgical resection extent on the prognosis of clinical stage I endometrial carcinoma].
    Yan X; Gao YN; Jiang GQ; Gao M; An N
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):208-12. PubMed ID: 19615262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.